Keyphrases
Androgen Deprivation Therapy
20%
Antidiabetic Drugs
13%
Antiepileptic Drugs
6%
Antihypertensive Drugs
6%
Atorvastatin
11%
Breast Cancer
6%
Cancer Mortality
10%
Castration-resistant Prostate Cancer
7%
Cholesterol Levels
6%
Confidence Interval
9%
Drug Use
12%
EPIC-26
6%
Expanded Prostate Cancer Index Composite
7%
Finland
18%
Finnish Population
6%
Functional Outcome
10%
Hazard Ratio
9%
High-grade Prostate Cancer
9%
Inguinal Hernia Repair
6%
Laparoscopic Prostatectomy
9%
Laparoscopic Radical Prostatectomy
6%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
10%
Metformin
7%
National Cohort Study
9%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
9%
Overall Survival
7%
Polygenic Risk Score
6%
Population-based Case-control Study
6%
Population-based Cohort
7%
Population-based Cohort Study
9%
Prostate
8%
Prostate Cancer
80%
Prostate Cancer Patients
6%
Prostate Cancer Prognosis
7%
Prostate Cancer Progression
6%
Prostate Cancer Risk
49%
Prostate Cancer Screening
13%
Prostate Cancer Survival
9%
Prostate Radiotherapy
8%
Prostate-specific Antigen
10%
Prostatectomy
11%
Radical Prostatectomy
21%
Randomized Clinical Trial
7%
Randomized Controlled Trial
6%
Renal Cancer
6%
Screening Trials
7%
Statin Use
18%
Statins
24%
Three-dimensional (3D)
11%
Visual Analog Scale
6%
Pharmacology, Toxicology and Pharmaceutical Science
Acetylsalicylic Acid
5%
Androgen
15%
Androgen Receptor
5%
Anticonvulsive Agent
6%
Antidiabetic Agent
7%
Antihypertensive Agent
6%
Atorvastatin
8%
Biological Marker
5%
Breast Cancer
6%
Cancer Incidence
7%
Cancer Mortality
19%
Cancer Prognosis
10%
Cancer Survival
11%
Case-Control Study
6%
Castration Resistant Prostate Cancer
12%
Cohort Study
17%
Comorbidity
5%
Diseases
5%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
15%
Malignant Neoplasm
14%
Neoplasm
7%
Non-Steroidal Anti-Inflammatory Drug
12%
Prostate Cancer
100%
Prostate Specific Antigen
14%
Statin (Protein)
24%
Medicine and Dentistry
Androgen Deprivation Therapy
7%
Antidiabetic Agent
9%
Cancer Cell
7%
Cancer Growth
7%
Cancer Mortality
11%
Cohort Analysis
10%
Continence
5%
Hernioplasty
6%
Incontinence
5%
Inguinal Hernia
6%
Malignant Neoplasm
5%
Neoplasm
10%
Personalized Medicine
6%
Prostate Cancer
70%
Prostate Specific Antigen
11%
Prostatectomy
32%
Randomized Controlled Trial
6%
Statin
5%
Urinary System
7%
Visual Analog Scale
6%